CTEV
Claritev Corporation
NYSE: CTEV · HEALTHCARE · HEALTH INFORMATION SERVICES
$28.53
-6.27% today
Updated 2026-06-05
Market cap
$447.85M
P/E ratio
—
P/S ratio
0.46x
EPS (TTM)
$-17.33
Dividend yield
—
52W range
$12 – $74
Volume
0.1M
WallStSmart proprietary scores
34
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C5.5
Quality
C+3.5
Profitability
D5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
-0.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$36.83
+29.09%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity -19.11x — low leverage
Risks
- Altman Z -0.49 — distress zone
- Thin margins at -29.30%
- Negative free cash flow $-95.41M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.08B | $961.52M | $930.62M | $965.41M | $978.76M |
| Net income | $-572.91M | $-91.70M | $-1.65B | $-284.28M | $-73.56M |
| EPS | — | — | — | — | $-17.33 |
| Free cash flow | $282.63M | $62.87M | $-10.51M | $-12.28M | $-95.41M |
| Profit margin | -53.06% | -9.54% | -176.85% | -29.45% | -29.30% |
Peer comparison
Smart narrative
Claritev Corporation trades at $28.53. Our Smart Value Score of 34/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -0.49, it sits in the distress. TTM revenue stands at $978.76M. with profit margins at -29.30%.
Frequently asked questions
What is Claritev Corporation's stock price?
Claritev Corporation (CTEV) trades at $28.53, on a P/S of 0.5x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Claritev Corporation overvalued?
Claritev Corporation carries a Smart Value Score of 34/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Claritev Corporation (CTEV)?
The 12-month analyst consensus target is $36.83, about 29.1% above the current $28.53. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is Claritev Corporation's revenue?
Claritev Corporation's trailing twelve-month revenue is $978.76M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Claritev Corporation's Altman Z-Score is -0.49, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTH INFORMATION SERVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.46x
ROE-646.00%
Beta0.77
50D MA$21.11
200D MA$37.96
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.1M
Performance
1 week+0.00%
1 month-6.31%
3 months+52.99%
YTD-39.56%
1 year—
3 years—
5 years—